We are live on ! Find out more
Pacer Advisors

Pacer Advisors Portfolio holdings

AUM $35.6B
1-Year Est. Return 18.19%
This Fund
S&P 500
This Quarter Est. Return
+7.06%
1 Year Est. Return
+18.19%
3 Year Est. Return
+46.13%
5 Year Est. Return
+70.99%
10 Year Est. Return
+394.12%
AUM
$2.66B
AUM Growth
+$447M
Cap. Flow
+$395M
Cap. Flow %
14.87%
Top 10 Hldgs %
18.05%
Holding
1,302
New
172
Increased
969
Reduced
51
Closed
109

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$18.9M
2
MSFT icon
Microsoft
MSFT
+$13.5M
3
AAPL icon
Apple
AAPL
+$12.1M
4
XOM icon
ExxonMobil
XOM
+$7.45M
5
META icon
Meta Platforms (Facebook)
META
+$7.29M

Sector Composition

Rank Sector Weight
1 Technology 21.37%
2 Healthcare 13.73%
3 Consumer Discretionary 11.89%
4 Financials 11.87%
5 Industrials 9.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RIGL icon
1126
Rigel Pharmaceuticals
RIGL
$680M
$62K ﹤0.01%
+1,924
New +$57.8K
VYGR icon
1127
Voyager Therapeutics
VYGR
$187M
$62K ﹤0.01%
+3,272
New +$62.8K
CBIO
1128
Crescent Biopharma
CBIO
$602M
$60K ﹤0.01%
+42
New +$63.5K
TGTX icon
1129
TG Therapeutics
TGTX
$8.58B
$60K ﹤0.01%
+10,626
New +$121K
DCPH
1130
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$60K ﹤0.01%
+1,544
New +$57.1K
BFX
1131
DELISTED
BowFlex Inc.
BFX
$59K ﹤0.01%
4,203
+2,666
+173% +$38.4K
SITC icon
1132
SITE Centers
SITC
$230M
$58K ﹤0.01%
5,513
-1,107
-17% -$12.1K
ANIK icon
1133
Anika Therapeutics
ANIK
$199M
$57K ﹤0.01%
1,354
+838
+162% +$33.1K
LXRX icon
1134
Lexicon Pharmaceuticals
LXRX
$1.02B
$57K ﹤0.01%
+5,387
New +$61.7K
BCRX icon
1135
BioCryst Pharmaceuticals
BCRX
$2.37B
$55K ﹤0.01%
+7,158
New +$48.1K
OUT icon
1136
Outfront Media
OUT
$5.64B
$51K ﹤0.01%
2,594
-182
-7% -$3.62K
INO icon
1137
Inovio Pharmaceuticals
INO
$79.8M
$50K ﹤0.01%
+747
New +$41.6K
ACHN
1138
DELISTED
Achillion Pharmaceuticals
ACHN
$50K ﹤0.01%
+13,474
New +$40.2K
RYTM icon
1139
Rhythm Pharmaceuticals
RYTM
$7B
$47K ﹤0.01%
+1,608
New +$50.8K
ROIC
1140
DELISTED
Retail Opportunity Investments Corp.
ROIC
$47K ﹤0.01%
2,526
-166
-6% -$3.17K
EPZM
1141
DELISTED
Epizyme, Inc
EPZM
$47K ﹤0.01%
+4,441
New +$50.7K
QTS
1142
DELISTED
QTS REALTY TRUST, INC.
QTS
$47K ﹤0.01%
1,104
+90
+9% +$3.93K
APLS
1143
DELISTED
Apellis Pharmaceuticals
APLS
$46K ﹤0.01%
+2,602
New +$48.1K
ATNX
1144
DELISTED
Athenex, Inc. Common Stock
ATNX
$46K ﹤0.01%
+147
New +$51.7K
KURA icon
1145
Kura Oncology
KURA
$922M
$44K ﹤0.01%
+2,518
New +$48.3K
AKBA icon
1146
Akebia Therapeutics
AKBA
$327M
$43K ﹤0.01%
+4,856
New +$43.4K
FPRX
1147
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$43K ﹤0.01%
+3,112
New +$46.3K
SGYP
1148
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$41K ﹤0.01%
+24,263
New +$43.4K
KERX
1149
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$41K ﹤0.01%
+12,009
New +$43.3K
ADC icon
1150
Agree Realty
ADC
$9.68B
$40K ﹤0.01%
760
-33
-4% -$1.79K

Similar funds

Pacer Advisors's Q3 2018 Portfolio in Review

As of Q3 2018, Pacer Advisors held 1,302 positions worth $2.66B, up 20% from $2.21B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Pacer Advisors deployed $395M of net new capital in Q3 2018, opening 172 new positions and adding to 969 existing holdings. Its largest new stake was VMware, Inc: 19,828 shares worth $3.09M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Wellcare Health Plans, Inc., an estimated $3.26M trimmed.

  • Pacer Advisors's largest Q3 2018 buy was VMware, Inc: 19,828 shares worth $3.09M.
  • Pacer Advisors added most to Amazon in Q3 2018, an estimated $18.9M increase.
  • Pacer Advisors's biggest Q3 2018 reduction was Wellcare Health Plans, Inc., cutting an estimated $3.26M.
  • Pacer Advisors fully exited BASF AKTIENGESELLT ADS(RP1 ORD in Q3 2018, selling an estimated $7.2M.
  • Pacer Advisors's ten largest holdings make up 18% of its $2.66B portfolio in Q3 2018.
  • Pacer Advisors opened 172 new positions and closed 109 in Q3 2018.
  • Pacer Advisors's portfolio value rose 20% quarter-over-quarter to $2.66B.

Based on Pacer Advisors's 13F filing for Q3 2018, filed 14 Nov 2018.